ArticleJournal of diabetes and metabolic disorders2021

Impact of combined therapy of mesenchymal stem cells and sitagliptin on a metabolic syndrome rat model.

Yossra Ahmed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.